Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

A. Burfsky, P. Fontaine-Rothe, K. Barlane, P. Rieker, M. R. Jiroutek, I. Kaplan, D. Kaufman, P. Kantoff

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalUrology
Volume49
DOIs
StatePublished - Jun 1 1997

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this